GLENMARK₹2,166.60-1.45%
Ownership Score
Index Membership
and the weight we carryMutual Fund Ownership
% of each scheme's portfolioInsider & Deals
who traded, and how close they are to the companyGLENMARK shareholding summary
As of Jun 2026, promoters held 46.65% of Glenmark Pharmaceuticals Ltd. Institutions together held 39.49%, of which foreign institutional investors held 20.89% (up 0.54 points from Mar 2026) and domestic institutions held 18.60% (down 0.68 points from Mar 2026). The public held the remaining 13.81% (up 0.11 points from Mar 2026). The company had 2,11,418 shareholders.
| Promoters | 46.65% |
|---|---|
| FII | 20.89% |
| DII | 18.60% |
| Public | 13.81% |